Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.

Miao L, Xiong X, Lin Y, Cheng Y, Lu J, Zhang J, Cheng N.

Cancer Genet. 2014 Mar;207(3):75-82. doi: 10.1016/j.cancergen.2014.02.008. Epub 2014 Feb 27.

PMID:
24726291
2.

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH.

J Cell Biochem. 2011 Sep;112(9):2296-306. doi: 10.1002/jcb.23150. Erratum in: J Cell Biochem. 2016 Aug;117(8):1963.

3.

MicroRNA-194 inhibits the epithelial-mesenchymal transition in gastric cancer cells by targeting FoxM1.

Li Z, Ying X, Chen H, Ye P, Shen Y, Pan W, Zhang L.

Dig Dis Sci. 2014 Sep;59(9):2145-52. doi: 10.1007/s10620-014-3159-6. Epub 2014 Apr 19.

PMID:
24748184
4.
5.

7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.

Cao X, Ren K, Song Z, Li D, Quan M, Zheng Y, Cao J, Zeng W, Zou H.

Oncol Rep. 2016 Aug;36(2):1157-65. doi: 10.3892/or.2016.4848. Epub 2016 Jun 2.

PMID:
27279287
6.

FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.

7.

Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.

Yu C, Chen L, Yie L, Wei L, Wen T, Liu Y, Chen H.

Oncol Rep. 2015 May;33(5):2402-10. doi: 10.3892/or.2015.3834. Epub 2015 Mar 4.

PMID:
25738652
8.

MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.

Feng J, Wang X, Zhu W, Chen S, Feng C.

Biochemistry (Mosc). 2017 Jun;82(6):707-714. doi: 10.1134/S0006297917060074.

PMID:
28601080
9.
10.

FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.

Huang C, Xie D, Cui J, Li Q, Gao Y, Xie K.

Clin Cancer Res. 2014 Mar 15;20(6):1477-88. doi: 10.1158/1078-0432.CCR-13-2311. Epub 2014 Jan 22.

11.
12.

7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.

Xiang HL, Liu F, Quan MF, Cao JG, Lv Y.

World J Gastroenterol. 2012 Sep 7;18(33):4618-26. doi: 10.3748/wjg.v18.i33.4618.

13.

Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition.

Balli D, Ustiyan V, Zhang Y, Wang IC, Masino AJ, Ren X, Whitsett JA, Kalinichenko VV, Kalin TV.

EMBO J. 2013 Jan 23;32(2):231-44. doi: 10.1038/emboj.2012.336. Epub 2013 Jan 4.

14.

FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.

Yang C, Chen H, Tan G, Gao W, Cheng L, Jiang X, Yu L, Tan Y.

Cancer Lett. 2013 Oct 28;340(1):104-12. doi: 10.1016/j.canlet.2013.07.004. Epub 2013 Jul 12.

PMID:
23856032
15.

FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.

Zeng J, Wang L, Li Q, Li W, Björkholm M, Jia J, Xu D.

J Pathol. 2009 Aug;218(4):419-27. doi: 10.1002/path.2530.

PMID:
19235838
17.

Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.

Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M, Guo YH, Shi J, Gong XD, Zhu YL, Liu F, Zhang WY, Jiang B.

Oncol Rep. 2014 Jun;31(6):2660-8. doi: 10.3892/or.2014.3129. Epub 2014 Apr 4.

PMID:
24715097
18.

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.

Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S656-64. doi: 10.1245/s10434-012-2217-6. Epub 2012 Feb 4.

PMID:
22311119
19.

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.

Chiu WT, Huang YF, Tsai HY, Chen CC, Chang CH, Huang SC, Hsu KF, Chou CY.

Oncotarget. 2015 Feb 10;6(4):2349-65.

20.

miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.

Sun Y, Yu X, Bai Q.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12775-83. eCollection 2015.

Supplemental Content

Support Center